Skip to main content
Top
Published in: Journal of General Internal Medicine 2/2018

01-02-2018 | Concise Research Reports

What Does ‘Unpaid Consultant’ Signify? A Survey of Euphemistic Language in Conflict of Interest Declarations

Authors: David B. Menkes, MD, PhD, Jill D. Masters, Dip-CH, Angela Bröring, Dip-Paed, MLIS, Alan Blum, MD

Published in: Journal of General Internal Medicine | Issue 2/2018

Login to get access

Abstract

Background and Objective

Inadequate competing interest declarations present interpretive challenges for editors, reviewers, and readers. We systematically studied a common euphemism, ‘unpaid consultant,’ to determine its occurrence in declarations and its association with vested interests, authors, and journals.

Methods

We used Google Scholar, a search engine that routinely includes disclosures, to identify 1164 occurrences and 787 unique biomedical journal publications between 1994 and 2014 that included one or more authors declaring themselves as an “unpaid consultant.” Changes over time were reckoned with absolute and relative yearly rates, the latter normalized by overall biomedical publication volumes. We further analyzed declarations according to author, consultancy recipient, and journal.

Results

We demonstrate increases in the use of “unpaid consultant” since 2004 and show that such uninformative declarations are overwhelmingly (801/865, 92.6%) associated with for-profit companies and other vested interests, most notably in the pharmaceutical, device, and biotech industries.

Conclusions

Disclosing ‘unpaid’ relationships with for-profit companies typically signals but does not explain competing interests. Our findings challenge editors to respond to the increasing use of language that may conceal rather than illuminate conflicts of interest.
Literature
1.
go back to reference Lo B. Commentary: Conflict of interest policies: an opportunity for the medical profession to take the lead. Acad Med. 2010;85:9-11.CrossRefPubMed Lo B. Commentary: Conflict of interest policies: an opportunity for the medical profession to take the lead. Acad Med. 2010;85:9-11.CrossRefPubMed
2.
go back to reference Loewenstein G, Sah S, Cain DM. The unintended consequences of conflict of interest disclosure. JAMA. 2012;307:669-70.CrossRefPubMed Loewenstein G, Sah S, Cain DM. The unintended consequences of conflict of interest disclosure. JAMA. 2012;307:669-70.CrossRefPubMed
3.
go back to reference Bero L. What is in a name? Nonfinancial influences on the outcomes of systematic reviews and guidelines. J Clin Epidemiol. 2014;67:1239-41.CrossRefPubMed Bero L. What is in a name? Nonfinancial influences on the outcomes of systematic reviews and guidelines. J Clin Epidemiol. 2014;67:1239-41.CrossRefPubMed
4.
6.
go back to reference Menkes DB, Bijl D. Credibility and trust are required to judge the benefits and harms of medicines. BMJ. 2017;358:j4204.CrossRefPubMed Menkes DB, Bijl D. Credibility and trust are required to judge the benefits and harms of medicines. BMJ. 2017;358:j4204.CrossRefPubMed
Metadata
Title
What Does ‘Unpaid Consultant’ Signify? A Survey of Euphemistic Language in Conflict of Interest Declarations
Authors
David B. Menkes, MD, PhD
Jill D. Masters, Dip-CH
Angela Bröring, Dip-Paed, MLIS
Alan Blum, MD
Publication date
01-02-2018
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 2/2018
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-017-4225-5

Other articles of this Issue 2/2018

Journal of General Internal Medicine 2/2018 Go to the issue

Clinical Practice: Exercises in Clinical Reasoning

Pivot and Cluster: An Exercise in Clinical Reasoning

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.